6-FLUOROBICYCLO 3.1.0 HEXAN-DERIVATE

Patent europeic · EP1459765 · Stritgà

Inscripziun en il register

Numer da publicaziun
EP1459765
Numer da la dumonda
EP02793421
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
Stritgà
Scrittira da patent
Concedì
Annunzià
26-12-2002
Publitgà
22-09-2004
Concedì
20-08-2008
Stritgà
31-12-2014
Motiv
Taxa annuala betg pajada
Classas IPC
A61K 45/00 (2006.01)
A61K 31/196 (2006.01)
A61K 31/381 (2006.01)
C07C 229/50 (2006.01)
C07C 255/54 (2006.01)
C07D 333/16 (2006.01)
A61P 25/18 (2006.01)
A61P 43/00 (2006.01)
Prioritad
JP 2001395797 27.12.2001
Dumonda PCT
PCT/JP2002/013693 26.12.2002
Publicaziun PCT
WO2003/061698 31.07.2003
Lingua da l’annunzia
giapunais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 22-07-2015

    Stritgà, taxa betg pajada

    Published in Swissreg on 22.07.2015

  2. 20-08-2008

    Concedì

    Published in Swissreg on 20.08.2008

  3. 20-08-2008

    Represchentant inscrit

    Representative
    E. Blum & Co. AG, Patent- und Markenanwälte VSP, Vorderberg 11, 8044 Zürich

    Published in Swissreg on 20.08.2008

Partidas

Inventur

NAKAZATO, Atsuro TAISHO PHARMACEUTICAL CO., LTD.

Toshima-ku, Tokyo 170-8633, JP

CHAKI, Shigeyuki TAISHO PHARMACEUTICAL CO., LTD.

Toshima-ku, Tokyo 170-8633, JP

SAKAGAMI, Kazunari TAISHO PHARMACEUTICAL CO., LTD.

Toshima-ku, Tokyo 170-8633, JP

DEAN, Ryoko TAISHO PHARMACEUTICAL CO., LTD.

Toshima-ku, Tokyo 170-8633, JP

OHTA, Hiroshi TAISHO PHARMACEUTICAL CO., LTD.

Toshima-ku, Tokyo 170-8633, JP

HIROTA, Shiho TAISHO PHARMACEUTICAL CO., LTD.

Toshima-ku, Tokyo 170-8633, JP

YASUHARA, Akito TAISHO PHARMACEUTICAL CO., LTD.

Toshima-ku, Tokyo 170-8633, JP

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.